Shinhan Financial Group Co., Ltd. 055550.KS KSC · Financials · South Korea
₩86,600.00 +1.17% +₩1,000.00
Summary
60 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Out of every 100 KRW of revenue, 19 KRW is left as net profit.
- Revenue grew by 12% a year over the last 3 years.
- It bought back its own shares for ₩1.25T in the last fiscal year, 3.2% of its market value.
What to watch
- Analysts expect revenue to fall by 52% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 7.1 KRW for 1 KRW of yearly profit. Over the last five years it was 5.3 KRW on average.
Valuation in detailIs it growing?
SlowlyRevenue (KRW)
Diluted EPS (KRW)
- Analyst estimate
Revenue grew by 6.2% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to fall by 52%. Earnings per share grew by 4.9% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 KRW of revenue goes
- Cost of sales 45 KRW
- Research and development 0.0 KRW
- Sales and administration 25 KRW
- Taxes and other 11 KRW
- Net profit 19 KRW
Net profit, industry median (Banks - Regional) 21 KRW
Out of every 100 KRW of revenue, 19 KRW is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.73%
- Paid out of profit
- 12%
You receive ₩1,480.00 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detail